Alzheimer's Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about Alzheimer's clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Not Applicable

TMS for Cognitive Decline in Aging and Preclinical AD

Cognitive DeclineHealthy AgingProdromal Alzheimer's Disease+1 more
Massachusetts General Hospital80 enrolled1 locationNCT06956300
Recruiting

Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia

Alzheimer's Disease (AD)Financial HardshipAlzheimer's Disease and Related Dementia (ADRD)
Fred Hutchinson Cancer Center2,460 enrolled1 locationNCT06922188
Recruiting

Cognitive Health in Ageing Register: Investigational and Observational Trial Studies in Dementia Research (CHARIOT): Prospective Readiness Cohort (PRO) Longitudinal Study

Alzheimer's Disease (AD)
Imperial College London600 enrolled1 locationNCT06953167
Recruiting
Not Applicable

Cervical Lymphatico-Venous Bypass for Treatment of Alzheimer's Disease - Proof of Concept Study (CLyVeB-AD-1 Study)

Alzheimer DiseaseAlzheimer's Disease (AD)Dementia Alzheimer Type+2 more
Vincent Tay Khwee Soon10 enrolled1 locationNCT06965062
Recruiting
Not Applicable

A Study of Silkworm Pupa Powder Intervention in the Nutritional Status of Patients With Alzheimer's Disease.

SarcopeniaAD - Alzheimer's DiseaseAsthenia
Zhejiang Hospital200 enrolled1 locationNCT07059871
Recruiting
Not Applicable

Improving Executive Control in Cognitively Healthy Older Adults: the MUltitasking STrategy (MUST) Study

Alzheimer's Disease (AD)Healthy Aging
Rutgers, The State University of New Jersey130 enrolled1 locationNCT06995638
Recruiting
Not Applicable

Effects of Transcranial Ultrasound Stimulation (TUS) on Neurological and Cognitive Outcomes in Neurodegenerative Diseases

Parkinson DiseaseAlzheimer's Disease (AD)Mild Cognitive Impairment+4 more
Sanmai Technologies PBC dba Sanmai20 enrolled1 locationNCT07207122
Recruiting

Evaluation of the Link Between Carotid Arterial Wall Viscosity and Major Neurocognitive Disorders

Neurocognitive DisordersAlzheimer's Disease
University Hospital, Rouen140 enrolled1 locationNCT07205003
Recruiting
Not Applicable

Safty and Efficacy of MCI Network Guided TMS for Early Alzheimer's Disease: A Randomized, Double-blind Trial

Alzheimer's DiseaseTranscranial Magnetic StimulationIndividualized Navigation
Anhui Medical University40 enrolled1 locationNCT07138677
Recruiting

Alzheimer's Disease Multinuclear Imaging Neuro-Enhanced Resolution (AD-MINER)

Alzheimer DiseaseMild Cognitive Impairment Due to Alzheimer's Disease
Chinese PLA General Hospital750 enrolled1 locationNCT07089303
Recruiting
Phase 2

Study to Evaluate the Efficacy and Safety of KDS2010 in Patients With Alzheimer's Disease With Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease

Mild Cognitive Impairment (MCI)Mild DementiaAlzheimer's Disease
NeuroBiogen Co., Ltd114 enrolled8 locationsNCT07027072
Recruiting

The Clinical Study of Synaptic Plasticity-based Lencanumab for the Treatment of Early Alzheimer's Disease

Alzheimer's DiseaseFunctional Magnetic Resonance ImagingLecanemab
Cuibai Wei,Clinical Professor120 enrolled1 locationNCT06871839
Recruiting
Phase 2

Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol

Healthy VolunteerAlzheimer's Disease, Mild Cognitive Impairment, Other Forms of Dementia
Akiva Mintz200 enrolled1 locationNCT07012993
Recruiting

Multimodal Ophthalmic Imaging and Plasma Biomarkers for the Early Detection of Alzheimer's Disease

Alzheimer's Disease (AD)
Peking University First Hospital200 enrolled1 locationNCT06924359